Alzheimers Detection

Alzheimer's disease and dementia are neurodegenerative conditions characterized by progressive cognitive decline. Early detection is crucial as it allows for timely intervention and management strategies to improve quality of life. Detection methods include cognitive tests assessing memory, problem-solving abilities, and language skills. Brain imaging techniques such as MRI and PET scans can reveal structural changes or abnormal protein deposits indicative of Alzheimer's. Biomarkers in cerebrospinal fluid or blood, like amyloid beta and tau proteins, are also used for diagnosis. Advances in AI and machine learning are enhancing detection accuracy by analyzing complex data patterns from brain scans and genetic information. Research continues to refine diagnostic tools, aiming for earlier and more precise identification of Alzheimer's, offering hope for effective treatments in the future.

Committee Members
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - London Jacqueline

London Jacqueline

Paris Diderot University, France
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jacqueline Tuppen

Jacqueline Tuppen

Cogs Club, United Kingdom
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Zhenhuan Liu

Zhenhuan Liu

Guangzhou University of Chinese Medicine, China

Submit your abstract Today

Whatsapp